AM Study Update: Full-Spectrum Cannabis Extract for Chronic Pain
This AM Study Update covers the latest research on full-spectrum cannabis extract chronic pain treatment. The phase 3 trial of Cannabis sativa extract DKJ127 shows promising results for chronic low back pain. Clinicians can use this evidence to guide…
AM Study Update: March 16, 2026
This cannabis research clinical update from March 16, 2026, summarizes 20 key studies from PubMed prioritized by clinical relevance. The update covers evidence on cannabis for chronic pain, anxiety, and adolescent health. Clinicians will find valuable…
endocannabinoid system clinical research: Phase 3 Cannabis Trial
Clinical Takeaway In this phase 3 randomized controlled trial of 820 adults, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks for chronic low back pain, with long-term follow-up extending to approximately one year.…
AM Study Update: March 11, 2026
This AM Study Update highlights cannabis clinical research 2026 with 20 prioritized studies from PubMed. The update covers clinical trials and systematic reviews relevant to cannabis medicine. Clinicians will find evidence-based insights for March 11,…
`Endocannabinoid System: Phase 3 Cannabis Trial for Back Pain`
Clinical Takeaway In this phase 3 randomized controlled trial, 820 adults with chronic low back pain received either VER-01, a full-spectrum cannabis extract, or placebo over 12 weeks, with extensions up to approximately one year. The trial was designed…
Cannabinoid Clinical Trials: Full-Spectrum Cannabis for Back Pain
This phase 3 trial evaluated the full-spectrum cannabis extract for chronic low back pain in 820 adults. The study showed pain reduction and sustained benefits over 12 months. Full-spectrum cannabis extract offers a promising option for patients with…
Endocannabinoid System Trial: Cannabis for Chronic Back Pain
Clinical Takeaway In this phase 3 randomized controlled trial, 820 adults with chronic low back pain received either VER-01, a full-spectrum cannabis extract, or placebo over a 12-week double-blind period, with extensions lasting up to an additional…
Endocannabinoid System & Cannabis for Chronic Back Pain Trial
This phase 3 full-spectrum cannabis extract trial evaluated VER-01 for chronic low back pain in 820 adults. The study demonstrated significant pain reduction and good tolerability. These results support the potential of cannabis extract as an alternative…
Medical Cannabis Evidence-Based Care: Phase 3 Trial Results
This phase 3 cannabis trial chronic low back pain study evaluated the full-spectrum cannabis extract VER-01 in 820 adults. The trial demonstrated significant pain reduction over 12 weeks with sustained effects. These results provide important evidence…